Zyomyx Point-of-Care CD4 Test was selected by the CD4 Initiative to help diagnose HIV/AIDS in patients in developing countries. This innovative test is as fast and easy as a pregnancy test.
Zyomyx, Inc. is an innovator in bioanalysis platforms based on its expertise in assay development, surface chemistry, and microsystem technologies. The Zyomyx product development infrastructure and suite of proprietary assay and surface technologies are ideally suited for the robust development of advanced but simple and inexpensive diagnostics such as the CD4 cell counting product.
Tags: Health Care, Medical Device